Share on LinkedInShare on LinkedIn

ARTICLE · 05 FEBRUARY 2025

DOL Clarifies Employees May Use FMLA For Clinical Trial Participation

The U.S. Department of Labor (DOL) issued DOL Opinion Letter FMLA2024-01-A on November 8, 2024. The Opinion Letter clarifies that eligible employees may take leave...

United StatesEmployment and HR

The U.S. Department of Labor (DOL) issued DOL Opinion Letter FMLA2024-01-A on November 8, 2024. The Opinion Letter clarifies that eligible employees may take leave under the Family and Medical Leave Act (FMLA) when "continuing treatment" of a serious health condition includes participation in a clinical trial.

The FMLA provides up to 12 weeks of protected leave time for treating serious health conditions and other family and health-related reasons. Generally, employers with 50 or more employees must permit FMLA leave and continue to provide coverage under their group health plans. Employees must work for the employer for at least a year and work a certain number of hours in 12 months to qualify for FMLA leave.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from